WebJul 26, 2024 · The first joint project for GSK and 23andMe will test the drugmaker’s small-molecule inhibitor of leucine-rich repeat kinase 2 (LRRK2), a protein that is mutated in about 1–2% of people with ... WebJul 25, 2024 · GlaxoSmithKline Plc is acquiring a $300 million stake in genetic-testing company 23andMe Inc. and revamping its approach to research And revamping its …
Press Release - 23andMe Media Center
WebMar 1, 2024 · 23andMe became the first organization of its type to win approval from the FDA to market genetic tests for cancer directly to customers without the need for a doctor’s order. During the first quarter of 2024, the company spent … WebJul 19, 2024 · The genetic insights that 23andMe have compiled seem to hold promise, but these first trials (GSK'608 and P006) will need to be monitored. If initial success is seen, 23andMe's upside story may be ... glastonbury 10 day weather forecast
23andMe and GSK Begin First Clinical Trial with Cancer …
WebDec 1, 2024 · The GSK deal was inked in July 2024 and marked a four-year collaboration. At the time, they said they expected to progress several targets per year jointly, and would initially split evenly the development activity expenses. GSK made a $300 million equity investment in 23andMe. The first compound from the partnership entered the clinic in … WebAug 16, 2024 · Hal Barron, MD. In July, GlaxoSmithKline (GSK), a prominent player in the drug development space, announced an exclusive multi-year partnership with popular direct-to-consumer genetic testing company 23andMe. The partnership is aimed at identifying novel drug targets, addressing new disease subsets, and increasing the speed of clinical … WebJan 18, 2024 · SUNNYVALE, Calif., Jan. 18, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (“23andMe”), a leading consumer genetics and therapeutics company, today provided an update on its collaboration with GlaxoSmithKline plc (“GSK”). glastonbury 022